Open

Do GLP-1 receptor agonists improve pharmacokinetics & dosing more than other treatments?

Also asked versus placebo.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

Unlikely. So far, the results disagree.

NoUnsureYes
Belief
0.00 (range 0.00–0.55)
Trials for
0
Trials against
1
Inconclusive
0

Already under way

No registered trial that could settle this is recruiting or active.

The evidence so far

Registered trials
218
With posted results
60
Published papers
3

Of 11 decided analyses: 0 favor glp-1 receptor agonists, 11 find no difference, 0 favor the comparator.

Papers

Trials

See every trial in the evidence map →